DNA-based test can spot cancer recurrence a year before conventional scans. ‘Liquid biopsy’ diagnosed cancer recurrence up to a year before CT scans are able to in major lung cancer trial, and could buy crucial time for doctors.

See the source article by following the link below:
DNA-based test can spot cancer recurrence a year before conventional scans. ‘Liquid biopsy’ diagnosed cancer recurrence up to a year before CT scans are able to in major lung cancer trial, and could buy crucial time for doctors.